Theiler M, Luchsinger I, Rast A C, Schwieger-Briel A, Weibel L, Bosshard P P
Dermatology Department, Pediatric Skin Center, University Children's Hospital Zurich, Zurich, Switzerland.
Center for Dermatology & Allergology, Lucerne Cantonal Hospital, Luzern, Switzerland.
J Eur Acad Dermatol Venereol. 2025 Feb;39(2):398-403. doi: 10.1111/jdv.20147. Epub 2024 May 31.
Tinea capitis (TC) is the most frequent dermatophyte infection in children requiring systemic and topical treatment for several weeks. Traditionally, diagnosis and treatment monitoring were based on microscopic examination and fungal culture of scales and plucked hairs, which both have significant limitations.
To investigate the role of dermatophyte polymerase chain reaction (PCR) in the treatment of TC.
Scales and plucked hairs of children with TC were investigated by dermatophyte PCR, microscopic examination and fungal culture at baseline and during antifungal treatment.
Seventeen children with TC were included. At baseline, sensitivity of PCR was 100% as compared to 60% and 87% for direct microscopy and fungal culture, respectively. Species identification by PCR and fungal culture was consistent in all cases. During follow-up, analysis of 38 samples under treatment showed a sensitivity of PCR, direct microscopy and fungal culture of 68%, 26% and 89% while specificity was 84%, 100% and 100%, respectively. PCR during therapy proved to be false-negative in six and false-positive in three instances. The latter turned negative after 4 weeks without further systemic treatment.
Dermatophyte PCR is an excellent tool for baseline diagnostics of TC providing rapid and accurate results. Our findings suggest that due to the fast and reliable results, it may replace direct microscopy and fungal culture to confirm or exclude TC in children. In the treatment course, diagnostic accuracy and performance of PCR seem reduced as compared to fungal culture, limiting its value for treatment monitoring. Mycological cure ascertained by fungal culture should currently remain the therapeutic goal.
头癣(TC)是儿童中最常见的皮肤癣菌感染,需要进行数周的全身和局部治疗。传统上,诊断和治疗监测基于鳞屑和拔下毛发的显微镜检查及真菌培养,这两种方法都有显著局限性。
探讨皮肤癣菌聚合酶链反应(PCR)在头癣治疗中的作用。
对头癣患儿的鳞屑和拔下毛发在基线时及抗真菌治疗期间进行皮肤癣菌PCR、显微镜检查和真菌培养。
纳入了17名头癣患儿。在基线时,PCR的敏感性为100%,而直接显微镜检查和真菌培养的敏感性分别为60%和87%。PCR和真菌培养的菌种鉴定在所有病例中均一致。在随访期间,对38份治疗中的样本分析显示,PCR、直接显微镜检查和真菌培养的敏感性分别为68%、26%和89%,而特异性分别为84%、100%和100%。治疗期间的PCR在6例中被证明为假阴性,在3例中为假阳性。后者在未进行进一步全身治疗的4周后转为阴性。
皮肤癣菌PCR是头癣基线诊断的优秀工具,能提供快速准确的结果。我们的研究结果表明,由于结果快速可靠,它可能取代直接显微镜检查和真菌培养来确诊或排除儿童头癣。在治疗过程中,与真菌培养相比,PCR的诊断准确性和性能似乎有所降低,限制了其在治疗监测中的价值。目前,真菌培养确定的真菌学治愈仍应是治疗目标。